An Original Microhaemorheological Approach to the Pharmacological Effects of Daflon 500 mg in Severe Chronic Venous Insufficiency

Skip Nav Destination

International Journal of Microcirculation (1995) 15 (Suppl. 1): 50–54.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review

Ke Xuan Li
Gisele Diendéré
Jean‐Philippe Galanaud
Nada Mahjoub
Susan R. Kahn

Research and Practice in Thrombosis and Haemostasis (2021) 5 (4): e12527.

Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study

Evgeny A. Zagriadskiĭ
Alexey M. Bogomazov
Evgeny B. Golovko

Advances in Therapy (2018) 35 (11): 1979.

Quantitative Measurement of Erythrocyte Aggregation as a Systemic Inflammatory Marker by Ultrasound Imaging: A Systematic Review

Prajwal Gyawali
Daniela Ziegler
Jean-François Cailhier
André Denault
Guy Cloutier

Ultrasound in Medicine & Biology (2018) 44 (7): 1303.

Health-promoting effects of the citrus flavanone hesperidin

Chaoyun Li
Hermann Schluesener

Critical Reviews in Food Science and Nutrition (2017) 57 (3): 613.

MODERN POSSIBILITIES TO PREVENTION AND TREATMENT OF HEMORRHOIDS IN PRENATAL AND EARLY POSTNATAL PERIOD

S. V. Vasiliev
D. E. Popov
A. I. Nedozimovany
O. S. Sokolova

Koloproktologia (2016) (3): 13.

Intradermal Therapy (Mesotherapy) with Lymdiaral in Chronic Venous Insufficiency and Associated Fibrosclerotic Edema Damage: A Pilot Study

Enrica Maggiori
Emanuele Bartoletti
Massimo Mammucari

The Journal of Alternative and Complementary Medicine (2013) 19 (9): 777.

Prise en charge des affections veineuses chroniques des membres inférieurs

A. Nicolaides
C. Allegra
J. Bergan
A. Bradbury
M. Cairols
P. Carpentier
A. Comerota
C. Delis
B. Eklof
N. Fassiadis
N. Georgiou
G. Geroulakos
U. Hoffmann
G. Jantet
A. Jawien
S. Kakkos
E. Kalodiki
N. Labropoulos
P. Neglen
P. Pappas
H. Partsch
M. Perrin
E. Rabe
A.A. Ramelet
M. Vayssairat

Journal des Maladies Vasculaires (2009) 34 (4): 1.

Protective Activity of Hesperidin and Lipoic Acid Against Sodium Arsenite Acute Toxicity in Mice

Ricardo N. Pires Das Neves
Félix Carvalho
Márcia Carvalho
Eduarda Fernandes
Elisa Soares
Maria De Lourdes Bastos
Maria De Lourdes Pereira

Toxicologic Pathology (2004) 32 (5): 527.

From Symptoms To Leg Edema: Efficacy Of Daflon 500 mg

Andrew N. Nicolaides

Angiology (2003) 54 (1_suppl): S33.

Chemistry and pharmacology of the citrus bioflavonoid hesperidin

A. Garg
S. Garg
L. J. D. Zaneveld
A. K. Singla

Phytotherapy Research (2001) 15 (8): 655.

Dorsal Pedal Venous Oximetry for Assessing Treatment of Chronic Venous Insufficiency: Effects of Daflon 500 mg

Behçet K. Ener

Vascular Surgery (2000) 34 (1): 43.

Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon

Robert W. Frick
Robert W. Frick

Angiology (2000) 51 (3): 197.

Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot study

S.Sulaiman Shoab
J.B. Porter
J.H. Scurr
P.D. Coleridge-Smith

Journal of Vascular Surgery (2000) 31 (3): 456.

Endothelial Activation Response to Oral Micronised Flavonoid Therapy in Patients with Chronic Venous Disease – a Prospective Study

S.S Shoab
J Porter
J.H Scurr
P.D Coleridge-Smith

European Journal of Vascular and Endovascular Surgery (1999) 17 (4): 313.

An Original Microhaemorheological Approach to the Pharmacological Effects of Daflon 500 mg in Severe Chronic Venous Insufficiency

INFORMATION

ABOUT US

SERVICES FOR

Karger International

An Original Microhaemorheological Approach to the Pharmacological Effects of Daflon 500 mg in Severe Chronic Venous Insufficiency

This Feature Is Available To Subscribers Only